NCT01171183

Carvedilol for Psychostimulant Dependence

Clinical Efficacy of Carvedilol for Psychostimulant Dependence

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: University of Arkansas · Academic / Other
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

This study examines whether carvedilol prolongs abstinence in recently abstinent cocaine dependent participants.

Conditions

• Cocaine Dependence
• Cocaine Withdrawal

Interventions

Type	Name	Description
DRUG	controlled release carvedilol	carvedilol (Coreg CR) 80 mg/day in once daily dosing for 12 weeks followed by a 2-week taper
DRUG	Placebo	Placebo

Timeline

• Start date: 2010-08-01
• Primary completion: 2014-05-01
• Completion: 2014-05-01
• First posted: 2010-07-28
• Last updated: 2015-07-31
• Results posted: 2015-07-31

Locations

1 site across 1 country: United States